Bae Sunjae, Garonzik-Wang Jacqueline M, Massie Allan B, McAdams-DeMarco Mara A, Coresh Josef, Segev Dorry L
Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Clin Transplant. 2021 Feb;35(2):e14176. doi: 10.1111/ctr.14176. Epub 2020 Dec 12.
Approximately 30% of kidney transplant recipients undergo early steroid withdrawal (ESW) for maintenance immunosuppression. However, there is no consensus on which patients are suitable for ESW, and transplant centers may disagree on how various clinical factors characterize individual recipients' suitability for ESW.
To examine center-level variation in the association of clinical factors with the choice of ESW, we studied 206 544 kidney transplant recipients from 278 centers in 2002-2017 using SRTR data. We conducted multi-level logistic regressions to characterize the association of clinical factors with the choice of ESW at each transplant center.
The association of clinical factors with the choice of ESW varied substantially across centers. We found particularly greater inconsistency in recipient age, PRA, re-transplantation, living/deceased donor, post-transplant length of stay, and delayed graft function. For example, across the entire population, re-transplantation was associated with lower odds of ESW (population odds ratio = 0.40 ). When estimated at each center, this odds ratio was significantly lower than the population odds ratio at 48 (17.3%) centers and significantly higher at 28 (10.1%) centers.
We have observed apparent inconsistencies across transplant centers in the practice of tailoring ESW to the recipient's risk profile. Standardized guidelines for ESW tailoring are needed.
约30%的肾移植受者在维持免疫抑制治疗时接受早期停用类固醇(ESW)。然而,对于哪些患者适合ESW尚无共识,而且各移植中心对于各种临床因素如何界定个体受者是否适合ESW可能存在分歧。
为研究临床因素与ESW选择之间关联在中心层面的差异,我们利用器官获取与移植网络(SRTR)数据,对2002年至2017年来自278个中心的206544例肾移植受者进行了研究。我们进行了多层次逻辑回归分析,以描述每个移植中心临床因素与ESW选择之间的关联。
临床因素与ESW选择之间的关联在各中心之间存在很大差异。我们发现,在受者年龄、群体反应性抗体(PRA)、再次移植、活体/已故供体、移植后住院时间以及移植肾功能延迟恢复等方面,不一致性尤为明显。例如,在整个人群中,再次移植与ESW几率较低相关(总体优势比=0.40)。在每个中心进行估计时,这一优势比在48个(17.3%)中心显著低于总体优势比,在28个(10.1%)中心显著高于总体优势比。
我们观察到,在根据受者风险状况调整ESW的实践中,各移植中心存在明显的不一致。需要制定ESW调整的标准化指南。